United States-based Medivant Healthcare has donated 5,000 vials of Lidocaine one percent Single Dose Injectables to Lake Charles Memorial Hospital, it was reported on Monday.
The company has taken this step following the devastation caused by Hurricane Laura. Presently, the product is required to sustain US Hospital Emergency Rooms and ICUs.
Founder of Medivant Healthcare, Viraj Gandhi, said, 'Generic Medicine Made in the USA, For the USA', is not just our slogan, it's what we do on a daily basis. Being located in Arizona, we are able to deliver our generics anywhere in the US, within a day or two. When tragedy hits our nation, such as Covid-19, Natural Disasters and other Perils, we don't just sell, we give. Our hearts go out to those who are suffering from the devastation in Lake Charles, due to Hurricane Laura. We hope our donation makes a difference, helping the hospital, their patients and their families in the community.'
Par Health launches generic version of Janumet XR tablets in US
EQL Pharma gains approval to sell Mellozzan in Kazakhstan
Newbury Pharmaceuticals receives Swedish approval for generic tofacitinib
Breckenridge launches Tofacitinib Tablets, generic equivalent to Pfizer's Xeljanz
Hims & Hers expands GLP-1 offering in Canada with generic semaglutide
Apotex announces commercial launch of Apo-Semaglutide Injection in Canada
Transpire Bio's generic high-strength Trelegy Ellipta ANDA accepted for filing by US FDA
Kaiser Permanente reports study findings showing significant cost savings
Apotex receives Health Canada approval for a generic Ozempic equivalent
Cipla's AB-rated Ventolin HFA generic receives US FDA approval
Newbury Pharmaceuticals secures first Scandinavian approval for palbociclib generic
Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval
DifGen and Apotex report FDA approval of generic Nintedanib Soft Gel Capsules